Search Results - "Siddals, Kirk W"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome by KAUSHAL, Kalpana, HEALD, Adrian H, SIDDALS, Kirk W, SANDHU, Manjinder S, DUNGER, David B, GIBSON, John M, WAREHAM, Nick J

    Published in Diabetes care (01-11-2004)
    “…The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome Kalpana Kaushal , MD 1 , Adrian H. Heald , DM 1 , Kirk W. Siddals , PHD 1…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathways by Siddals, Kirk W, Marshman, Emma, Westwood, Melissa, Gibson, J Martin

    Published in The Journal of biological chemistry (10-09-2004)
    “…The vasculoprotective effects of hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors (statins) correlate with cholesterol lowering. HMG-CoA reductase…”
    Get full text
    Journal Article
  4. 4

    Reduced Pericellular Sensitivity to IGF-I in Fibroblasts From Girls With Turner Syndrome: A Mechanism to Impair Clinical Responses to GH by Westwood, Melissa, Tajbakhsh, Shahin H, Siddals, Kirk W, Whatmore, Andrew J, Clayton, Peter E

    Published in Pediatric research (01-07-2011)
    “…Girls with Turner syndrome (TS) are treated with supraphysiological doses of growth hormone (GH) to improve final height; however in some girls, the growth…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Atorvastatin administration is associated with dose-related changes in IGF bioavailability by Narayanan, Ram P, Gittins, Matthew, Siddals, Kirk W, Oliver, Robert L, Hudson, Julie E, White, Anne, Durrington, Paul, Davies, Robert R, Rutter, Martin K, Gibson, J Martin

    Published in European journal of endocrinology (01-04-2013)
    “…ObjectiveIGF levels, their binding proteins (IGFBPs) and high-dose statin therapy have been linked to the development of diabetes. We aimed to identify whether…”
    Get full text
    Journal Article
  7. 7

    IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes by Narayanan, Ram P, Fu, Bo, Heald, Adrian H, Siddals, Kirk W, Oliver, Robert L, Hudson, Julie E, Payton, Antony, Anderson, Simon G, White, Anne, Ollier, William E R, Gibson, J Martin

    Published in Endocrine Connections (01-11-2012)
    “…ObjectiveInsulin-like growth factors are implicated in the development of diabetic nephropathy. IGF-binding protein 2 (IGFBP2) and IGF2 are expressed in the…”
    Get full text
    Journal Article
  8. 8

    Abrogation of Insulin-like Growth Factor-I (IGF-I) and Insulin Action by Mevalonic Acid Depletion by Siddals, Kirk W., Marshman, Emma, Westwood, Melissa, Gibson, J. Martin

    Published in The Journal of biological chemistry (10-09-2004)
    “…The vasculoprotective effects of hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors (statins) correlate with cholesterol lowering. HMG-CoA reductase…”
    Get full text
    Journal Article
  9. 9

    The effect of atorvastatin on serum lipoproteins in acromegaly by Mishra, Manoj, Durrington, Paul, Mackness, Mike, Siddals, Kirk W., Kaushal, Kalpana, Davies, Rob, Gibson, Martin, Ray, David W.

    Published in Clinical endocrinology (Oxford) (01-06-2005)
    “…Objective Acromegaly is associated with long‐term adverse effects on cardiovascular mortality and morbidity. Reducing growth hormone secretion improves…”
    Get full text
    Journal Article
  10. 10